peaka glp-1 review 11 Side Effects You Should Know About Anti-obesity drugs for the gastroenterologist

From $149/mo Steady, sustained weight loss 20.2% Illustrative trajectory modeled on SURMOUNT-5 (NEJM, 2025), which reported a mean 20.2% body-weight reduction at 72 weeks with tirzepatide at the maximum tolerated dose

Type II diabetics with excessively high blood sugar are also at a greater risk of heart attack and stroke

They showed that 6 months of GLP-1-RA therapy provided 8.8% total weight loss and 2.9 kg/m 2 BMI loss

Food and Drug Administration Defining Adult Overweight and Obesity Centers for Disease Control and Prevention Clinical practice guidelines for obesity American Association of Clinical Endocrinology Try These Calculators More on This Topic Prova Guide Intermittent Fasting for Longevity: The 16:8 Protocol Deep Dive How intermittent fasting affects metabolism, body composition, and long-term health